Literature DB >> 15990077

Clinical manifestations of cutaneous lupus erythematosus.

Victoria P Werth1.   

Abstract

The skin findings seen in lupus erythematosus can present with either lupus-specific or lupus-nonspecific findings, with lupus-specific skin disease showing findings histopathologically distinct for cutaneous lupus erythematosus. Lupus-specific skin diseases include chronic cutaneous, subacute cutaneous, and acute cutaneous lupus erythematosus. The types of skin lesions in each group are clinically distinct and recognizing the specific subsets helps in prognosticating the likelihood of underlying systemic lupus. A number of medications are associated with cutaneous lupus, in particular with subacute cutaneous lupus erythematosus. Lupus nonspecific skin lesions are not histopathologically distinct for cutaneous lupus and/or may be seen as a feature of another disease process. Nonspecific disease-related skin lesions are frequently seen in patients with SLE, usually in the active phase of the disease. The current ACR classification criteria for SLE include four somewhat overlapping dermatologic criteria, butterfly rash, discoid lupus, photosensitivity, and oral ulcers and thus patients can be classified as having SLE with only skin manifestations.

Entities:  

Mesh:

Year:  2005        PMID: 15990077     DOI: 10.1016/j.autrev.2005.01.003

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  37 in total

Review 1.  Cutaneous findings in patients with primary Sjogren's syndrome.

Authors:  Mehmet Soy; Süleyman Piskin
Journal:  Clin Rheumatol       Date:  2006-08-17       Impact factor: 2.980

2.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 3.  The Cutaneous Spectrum of Lupus Erythematosus.

Authors:  Simone Ribero; Savino Sciascia; Luca Borradori; Dan Lipsker
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

4.  Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study.

Authors:  Abha G Singh; Cynthia S Crowson; Siddharth Singh; Mark Denis; P Davis; Hilal Maradit-Kremers; Eric L Matteson; Vaidehi R Chowdhary
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11       Impact factor: 4.794

5.  Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus.

Authors:  K Masek-Hammerman; E Peeva; A Ahmad; S Menon; M Afsharvand; R Peng Qu; J B Cheng; J Syed; Y Zhan; S P O'Neil; S Pleasic-Williams; L A Cox; D Beidler
Journal:  Clin Exp Immunol       Date:  2015-11-09       Impact factor: 4.330

6.  Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus.

Authors:  M E Ogunsanya; S K Cho; A Hudson; B F Chong
Journal:  Br J Dermatol       Date:  2019-04-07       Impact factor: 9.302

7.  Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.

Authors:  Yesenia Santiago-Casas; Luis M Vilá; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Elizabeth E Brown
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

8.  Cancer risk in cutaneous lupus erythematosus: a population-based cohort study.

Authors:  Abha G Singh; Cynthia S Crowson; Siddharth Singh; Mark Denis P Davis; Hilal Maradit-Kremers; Eric L Matteson; Vaidehi R Chowdhary
Journal:  Rheumatology (Oxford)       Date:  2016-08-12       Impact factor: 7.580

Review 9.  Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.

Authors:  Thrasivoulos George Tzellos; Dimitrios Kouvelas
Journal:  Eur J Clin Pharmacol       Date:  2007-12-20       Impact factor: 2.953

10.  Demographic and clinical characteristics of cutaneous lupus erythematosus at a paediatric dermatology referral centre.

Authors:  B Z Dickey; K E Holland; B A Drolet; S S Galbraith; V B Lyon; D H Siegel; Y E Chiu
Journal:  Br J Dermatol       Date:  2013-08       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.